Stocks and Investing Stocks and Investing
Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018

Do Kim Maintained (ALNY) at Buy with Decreased Target to $124 on, Oct 16th, 2018


Published on 2024-10-26 09:34:42 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Decreased Target from $125 to $124 on, Oct 16th, 2018.

Do has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Do's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018


These are the ratings of the 6 analyists that currently disagree with Do


  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $135 on, Monday, October 1st, 2018
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $117 on, Thursday, September 13th, 2018
  • Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
  • Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018